Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study

2002/03/01 by Marcia Cruz‐Correa, Marcia Cruz–Correa, Linda M. Hylind +4 · 28 citations
Medicine · #Adenoma #Cancer #Colorectal Cancer Screening and Detection #Colorectal cancer #Familial adenomatous polyposis #Gastroenterology #Genetic factors in colorectal cancer #Inflammatory mediators and NSAID effects #Internal medicine #Medicine #Nonsteroidal #Prospective cohort study #Rectal Polyp #Rectum #Sulindac #Surgery

paper · pdf · doi:10.1053/gast.2002.31890

openalex publication_date 2002/03/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/04

Cited by

• Chemoprevention of Colorectal Cancer
• Review article: the potential of combinational regimen with non‐steroidal anti‐inflammatory drugs in the chemoprevention of colorectal cancer
• Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
• Primary chemoprevention of familial adenomatous polyposis with sulindac. [europepmc]
• Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. [europepmc]
• Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines. [europepmc]
• Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis. [europepmc]
• Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives. [europepmc]
• Familial adenomatous polyposis. [europepmc]
• Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. [europepmc]
• Anti-Inflammatory Agents for Cancer Therapy. [europepmc]
• Primary prevention of colorectal cancer. [europepmc]
• Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins. [europepmc]
• The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac. [europepmc]
• Chemoprevention in familial adenomatous polyposis. [europepmc]
• Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling. [europepmc]
• Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update. [europepmc]
• Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. [europepmc]
• Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis. [europepmc]
• Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment. [europepmc]
• Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level. [europepmc]
• ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer. [europepmc]
• Chemoprevention of Colorectal Cancer. [europepmc]
• Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). [europepmc]
• Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention. [europepmc]
• Anti-Inflammatory Drugs as Anticancer Agents. [europepmc]
• Leukotrienes in Tumor-Associated Inflammation. [europepmc]
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. [europepmc]